Debevoise Advises Envision Healthcare in Its $15 Billion Merger with AMSURG

15 June 2016

Debevoise & Plimpton LLP is advising Envision Healthcare Holdings, Inc. (Envision) (NYSE:EVHC) in its merger with AMSURG Corp. (AMSURG) (NASDAQ:AMSG). Under the definitive merger agreement, the companies will combine in an all-stock transaction at a fixed exchange ratio of 0.334 AMSURG shares per Envision share. The combined organization will have a pro forma market capitalization of approximately $10 billion and enterprise value of $15 billion. Envision shareholders will own approximately 53% and AMSURG shareholders will own approximately 47% of the combined organization on a fully diluted basis, including preferred shares.

Upon completion of the merger, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The Company’s common stock will trade on the New York Stock Exchange under the ticker symbol: EVHC.

The Debevoise team is led by partners Paul S. Bird and Kevin A. Rinker and includes partners Peter A. Furci, Jonathan F. Lewis, Peter J. Loughran and Jeffrey E. Ross, and associates Stephen Asoli, Sean Foley, Douglas M. Hirn, Ross Liemer, Sue Meng, Ryan T. Rafferty, Molly F. Stockley and Aaron Christopher West.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.